These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37152807)

  • 1. Corrigendum to: The long non-coding RNA
    Neurooncol Adv; 2023; 5(1):vdad051. PubMed ID: 37152807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long non-coding RNA
    Lee B; Katsushima K; Pokhrel R; Yuan M; Stapleton S; Jallo G; Wechsler-Reya RJ; Eberhart CG; Ray A; Perera RJ
    Neurooncol Adv; 2022; 4(1):vdac120. PubMed ID: 36267874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long noncoding RNA
    Lee B; Sahoo A; Marchica J; Holzhauser E; Chen X; Li JL; Seki T; Govindarajan SS; Markey FB; Batish M; Lokhande SJ; Zhang S; Ray A; Perera RJ
    Sci Adv; 2017 May; 3(5):e1602505. PubMed ID: 28508063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: This is a corrigendum to: Kumthekar et al, A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac123, https://doi.org/10.1093/noajnl/vdac123.
    Neurooncol Adv; 2023; 5(1):vdad103. PubMed ID: 37664526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines.
    Cheung HC; Hai T; Zhu W; Baggerly KA; Tsavachidis S; Krahe R; Cote GJ
    Brain; 2009 Aug; 132(Pt 8):2277-88. PubMed ID: 19506066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A posttranscriptional mechanism that controls Ptbp1 abundance in the Xenopus epidermis.
    Méreau A; Anquetil V; Lerivray H; Viet J; Schirmer C; Audic Y; Legagneux V; Hardy S; Paillard L
    Mol Cell Biol; 2015 Feb; 35(4):758-68. PubMed ID: 25512611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: WGCNA Co-Expression Network Analysis Reveals ILF3-AS1 Functions as a CeRNA to Regulate PTBP1 Expression by Sponging miR-29a in Gastric Cancer.
    Ren ZH; Shang GP; Wu K; Hu CY; Ji T
    Front Genet; 2020; 11():585190. PubMed ID: 33133169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human Melanocytes.
    Zhao W; Mazar J; Lee B; Sawada J; Li JL; Shelley J; Govindarajan S; Towler D; Mattick JS; Komatsu M; Dinger ME; Perera RJ
    J Invest Dermatol; 2016 Apr; 136(4):819-828. PubMed ID: 26829028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypyrimidine tract binding proteins PTBP1 and PTBP2 interact with distinct proteins under splicing conditions.
    Pina JM; Hernandez LA; Keppetipola NM
    PLoS One; 2022; 17(2):e0263287. PubMed ID: 35113929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRSF1 and PTBP1 Are
    van Bergeijk P; Seneviratne U; Aparicio-Prat E; Stanton R; Hasson SA
    Mol Cell Biol; 2019 Sep; 39(18):. PubMed ID: 31208978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to: Epigenetic dysregulation in meningiomas.
    Neurooncol Adv; 2023; 5(1):vdac190. PubMed ID: 36632569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative splicing event amplifies evolutionary differences between vertebrates.
    Gueroussov S; Gonatopoulos-Pournatzis T; Irimia M; Raj B; Lin ZY; Gingras AC; Blencowe BJ
    Science; 2015 Aug; 349(6250):868-73. PubMed ID: 26293963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
    Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to: Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignancies.
    Neurooncol Adv; 2023; 5(1):vdad019. PubMed ID: 36923271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
    Neurooncol Adv; 2023; 5(1):vdad072. PubMed ID: 37303863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to: Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study.
    Neurooncol Adv; 2023; 5(1):vdad155. PubMed ID: 38077211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to: Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields.
    Neurooncol Adv; 2022; 4(1):vdac164. PubMed ID: 36325375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to: ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastoma.
    Nasir A; Cardall A; Othman RT; Nicolaou N; Lourdusamy A; Linke F; Onion D; Ryzhova M; Cameron H; Valente C; Ritchie A; Korshunov A; Pfister SM; Grabowska AM; Kerr ID; Coyle B
    Neurooncol Adv; 2021; 3(1):vdab155. PubMed ID: 34988447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to: Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing.
    Neurooncol Adv; 2023; 5(1):vdad005. PubMed ID: 36660081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.